SEC Form 10-K filed by General Purpose Acquisition Corp.
| ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| State or other jurisdiction of incorporation or organization | I.R.S. Employer Identification No. |
| Address of Principal Executive Offices | Zip Code |
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered |
| | | The |
| | | The |
| | | The |
| Large accelerated filer | ☐ | Accelerated filer | ☐ |
| | ☒ | Smaller reporting company | |
| Emerging growth company |
| PAGE | |
|
ii
|
|
|
iii
|
|
|
1
|
|
|
1
|
|
|
33
|
|
|
83
|
|
| 84 | |
|
84
|
|
|
84
|
|
|
84
|
|
|
85
|
|
|
85
|
|
|
86
|
|
|
86
|
|
|
89
|
|
| 89 | |
| 89 | |
|
90
|
|
| 90 | |
| 90 | |
|
91
|
|
|
91
|
|
|
101
|
|
|
102
|
|
|
108
|
|
|
112
|
|
|
112
|
|
|
112
|
|
|
113
|
|
| F-1 |
| • |
“amended and restated memorandum and articles association” refers to the amended and restated memorandum and articles association of the Company which were adopted prior to the consummation of our initial public offering;
|
| • |
“Companies Act” are to the Companies Act (Revised) of the Cayman Islands as the same may be amended from time to time;
|
| • |
“Company,” “we,” “us,” “our,” or “our Company” are to General Purpose Acquisition Corp., a Cayman Islands exempted company;
|
| • |
“Excise Tax” shall mean the 1% U.S. federal excise tax that was implemented by the Inflation Reduction Act of 2022;
|
| • |
“founders” are to Peter Georgiopoulos and Leonard Vrondissis;
|
| • |
“founder shares” are to our Class B ordinary shares initially issued to our sponsor in a private placement prior to our initial public offering and the Class A ordinary shares that will be issued upon the automatic conversion of the
Class B ordinary shares concurrently with or immediately following the consummation of our initial business combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment as described herein (for the
avoidance of doubt, such Class A ordinary shares are not “public shares” with redemption rights);
|
| • |
“initial public offering” are to the Company’s initial public offering of units, including any units sold in connection with the fully exercised over-allotment option granted to the underwriters of the Company’s initial public offering;
|
| • |
“management” or “our management team” are to our officers and directors;
|
| • |
“ordinary shares” are to our Class A ordinary shares and our Class B ordinary shares;
|
| • |
“permitted withdrawals” means amounts withdrawn or eligible to be withdrawn to pay for our taxes (which shall exclude the Excise Tax if any is imposed on us), such withdrawals can only be made from interest and not from the principal
held in the trust account;
|
| • |
“private placement units” are to the private placement units issued to our sponsor and to the underwriters in a private placement in connection with the closing of our initial public offering (which private placement units are identical
to the public units sold in our initial public offering, subject to certain limited exceptions as described in this Annual Report), or upon conversion of working capital loans, as further described in this Annual Report;
|
| • |
“private placement shares” are to the Class A ordinary shares underlying the private placement units issued to our sponsor and to the underwriters in a private placement in connection with the closing of our initial public offering, or
upon conversion of working capital loans, as further described in this Annual Report (such Class A ordinary shares delivered upon conversion shall not have any redemption rights or be entitled to liquidating distributions from the trust
account if we fail to consummate an initial business combination);
|
| • |
“private placement warrants” are to the non-redeemable warrants underlying the private placement units issued to our sponsor and to the underwriters in a private placement in connection with the closing of our initial public offering, or
upon conversion of working capital loans, as further described in this Annual Report;
|
| • |
“public shareholders” are to the holders of our public shares, including our sponsor and management team to the extent our sponsor and/or members of our management team purchase public shares, provided that our sponsor’s and each member
of our management team’s status as a “public shareholder” will only exist with respect to such public shares;
|
| • |
“public shares” are to our Class A ordinary shares sold as part of the public units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market);
|
| • |
“public units” are to the units sold at $10.00 per unit in the Company’s initial public offering (whether they are purchased in the Company’s initial public offering or thereafter in the open market, including units that may be acquired
by our sponsor or its affiliates in the open market following our initial public offering), each unit consisting of one public share and one-fifth of one public warrant;
|
| • |
“public warrants” are to the redeemable warrants sold as part of the public units in our initial public offering (whether they are purchased in our initial public offering or thereafter in the open market, including warrants that may be
acquired by our sponsor or its affiliates in the open market following our initial public offering);
|
| • |
“SEC” are to the U.S. Securities and Exchange Commission;
|
| • |
“sponsor” are to General Purpose Acquisition Corp Services LLC, a Cayman Islands limited liability company acting by its manager(s) from time to time. Peter Georgiopoulos and Leonard Vrondissis are the co-managers of the sponsor as of
the date of this Annual Report; and
|
| • |
“warrants” are to our redeemable public warrants and non-redeemable private placement warrants, as further described in this Annual Report.
|
| • |
we have no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective;
|
| • |
our ability to select an appropriate target business or businesses;
|
| • |
our ability to complete our initial business combination;
|
| • |
our expectations around the performance of a prospective target business or businesses;
|
| • |
our success in retaining or recruiting, or changes required in, our officers, key employees or directors following our initial business combination;
|
| • |
our officers and directors allocating their time to other businesses and potentially having conflicts of interest with our business or in approving our initial business combination;
|
| • |
our potential ability to obtain additional financing to complete our initial business combination;
|
| • |
our pool of prospective target businesses;
|
| • |
the amount of redemptions by our public shareholders in connection with amendments to our amended and restated memorandum and articles of association or the consummation of a business combination;
|
| • |
our ability to consummate an initial business combination due to the uncertainty resulting from general economic and political conditions such as recessions, interest rates, international currency fluctuations and health epidemics and
pandemics, inflation, changes in diplomatic and trade relationships and acts of war or terrorism (including the military conflict that started between the Russian Federation, Belarus and Ukraine in February 2022 or other geopolitical
tensions, such as an escalation of the conflict in the Middle East);
|
| • |
the ability of our officers and directors to generate a number of potential business combination opportunities;
|
| • |
our public securities’ potential liquidity, volatility and trading;
|
| • |
the use of proceeds not held in the trust account or available to us from interest income on the trust account balance;
|
| • |
the trust account not being subject to claims of third parties;
|
| • |
our financial performance; and
|
| • |
the other risks and uncertainties discussed in “Item 1A. Risk Factors” and elsewhere in this Annual Report.
|
| • |
Operating companies in the public and private markets, defining corporate strategy, and identifying, mentoring and recruiting top talent;
|
| • |
Growing companies, both organically and through strategic transactions, expanding product portfolios and broadening geographic footprints;
|
| • |
Strategically investing in leading private and public maritime, logistics, and digital infrastructure companies to help accelerate growth and maturation;
|
| • |
Sourcing, structuring, acquiring and selling businesses;
|
| • |
Accessing public and private capital markets to optimize capital structure, including financing businesses and helping companies transition ownership structures;
|
| • |
Fostering relationships with sellers, capital providers and experienced target management teams; and
|
| • |
Building companies with resilient and flexible business models that have had success in navigating multiple periods of economic drawdowns.
|
| • |
Will benefit from a public currency. Access to the public equity markets could allow the target company to utilize an additional form of capital, enhancing its ability to pursue accretive
acquisitions, high-return capital projects, and/or strengthen its balance sheet;
|
| • |
Has a healthy growing platform. We will seek to invest in companies that we believe possess attractive business models that will provide a growing platform for equity investors;
|
| • |
Has a management team and/or a strong sponsor that desires a significant equity stake in the post-business combination company. We will seek to partner with a management team and/or seller who is
well-incentivized and aligned in an effort to create shareholder value;
|
| • |
Can be acquired at an attractive valuation for public market investors. We will seek to be a disciplined steward of capital that will invest on terms that we believe provide attractive
risk-adjusted returns. We intend to focus on target companies with an approximate enterprise of $600 million - $1.8 billion;
|
| • |
Will be resilient to economic cycles. We will focus on recession-resilient business models; and
|
| • |
Are commercial stage assets that have an attractive cash flow profile and/or unit economics. We will seek to target businesses with attractive financial attributes.
|
|
SUBJECT
SECURITIES
|
TRANSFER RESTRICTIONS
|
NATURAL PERSONS AND
ENTITIES SUBJECT TO
TRANSFER
RESTRICTIONS
|
EXCEPTIONS TO
TRANSFER RESTRICTIONS
|
|||
|
Founder Shares
|
Agreement not to (a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent
position or liquidation with respect to or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act and the rules and regulations of the SEC promulgated thereunder with respect to, any security, (b) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or
otherwise, or (c) publicly announce any intention to effect any transaction specified in clause (a) or (b) (each of the foregoing, a “Transfer”), until the earlier of (A) one year following the completion of our initial business combination
and (B) subsequent to our initial business combination, the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to
exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 180 days after the completion of our initial business combination, the founder shares will be
released from the lock-up. Further, no Transfer of any Class A ordinary shares, Class B ordinary shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until May 31, 2026 (or 180 days following
the pricing of our initial public offering on December 2, 2025). Certain transfer restrictions pursuant to FINRA rules may also apply to any securities deemed underwriting compensation.
|
Our sponsor, directors and officers
|
Restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our
sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an
affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic
relations order; (e) by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units, private placement warrants,
private placement shares or Class A ordinary shares, as applicable, were originally purchased; (f) pro rata distributions from our sponsor to its members, partners, or shareholders pursuant to our sponsor’s operating agreement, (g) by
virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (h) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (i) in the event of
our liquidation prior to the completion of our initial business combination; or (j) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders having
the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the case of
clauses (a) through (g) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. Any permitted transferees would be
subject to the same restrictions and other agreements of our sponsor and management team with respect to any founder shares and private placement units (including their underlying securities). Further, despite the 180 day Transfer
restriction after May 31, 2026 (or 180 days following the pricing of our initial public offering on December 2, 2025 that is described under the column “Transfer restrictions” to the left of this column), the underwriting agreement
authorizes registration with the SEC pursuant to the Registration Rights and Shareholder Rights Agreement of the resale of the founder shares, the private placement units (including any private placement units issued upon conversion of
working capital loans) and their underlying securities, the exercise of the private placement warrants and the public warrants and the Class A ordinary shares issuable upon exercise of such warrants or conversion of founder shares.
|
|
Private Placement Units and underlying securities
|
No Transfer until 30 days after the completion of our initial business combination. Further, no Transfer of any Class A ordinary shares, Class B ordinary shares or any other securities convertible into, or exercisable or exchangeable
for, ordinary shares until May 31, 2026 (or 180 days following the pricing of our initial public offering on December 2, 2025). Certain transfer restrictions pursuant to FINRA rules may also apply to any securities deemed underwriting
compensation.
|
Our sponsor, directors and officers
|
Same as above. FINRA rule 5110(e)(2) includes certain limited exemption to the transfer restrictions applicable to securities deemed underwriting compensation pursuant to FINRA Rule 5110.
|
|
ENTITY/
INDIVIDUAL
|
AMOUNT OF COMPENSATION
RECEIVED OR TO BE RECEIVED OR
SECURITIES ISSUED
|
CONSIDERATION
|
||
|
Sponsor
|
5,750,000 founder shares(1)
|
$25,000 or approximately $0.004 per founder share
|
||
|
430,000 private placement units
|
||||
|
$25,000 per month
|
Office space, secretarial and administrative services
|
|||
|
$300,000
|
Repayment of loans made to us to cover our initial public offering related and initial organizational expenses
|
|||
|
Sponsor, officers or directors, or our or their affiliates
|
Up to $1,500,000 in working capital loans by our sponsor, our sponsor’s affiliates and our directors or officers. Such loans may be converted at the option of the lender into private placement units at a conversion price of $10.00 per
unit(2)
|
Working capital loans to fund working capital deficiencies or finance transaction costs in connection with an initial business combination
|
||
|
Reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such
persons in connection with activities on our behalf.(3)
|
Services in connection with identifying, investigating and completing an initial business combination
|
| (1) |
Subject to adjustment for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein, the founder shares, which are designated as Class B ordinary
shares, will be convertible at the option of the holder on a one-for-one basis or will automatically convert into Class A ordinary shares (such Class A ordinary share delivered upon conversion will not have any redemption rights or be
entitled to liquidating distributions from the trust account if we fail to consummate an initial business combination) concurrently with or immediately following the consummation of our initial business combination at a ratio such that the
number of Class A ordinary shares issuable upon conversion of all founder shares (including, for the avoidance of doubt for purposes of the calculation described hereafter, the Class A ordinary shares that may have been issued upon
conversion of Class B ordinary shares at the option of the holder thereof prior to the consummation of our initial business combination) will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of
ordinary shares issued and outstanding (excluding the private placement shares underlying private placement units) upon the consummation of our initial public offering, plus (ii) the sum of the total number of Class A ordinary shares issued
or deemed issued or issuable upon conversion or exercise of any equity-linked securities (as defined immediately below) or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial
business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial business combination
and any private placement-equivalent shares issued to our sponsor, members of our management team or any of their affiliates upon conversion of working capital loans made to the Company. Any conversion of Class B ordinary shares described
herein will take effect as a compulsory redemption of Class B ordinary shares and an issuance of Class A ordinary shares as a matter of Cayman Islands law. In no event will the Class B ordinary shares convert into Class A ordinary shares at
a rate of less than one-to-one. The term “equity-linked securities” refers to any debt or equity securities that are convertible, exercisable or exchangeable for our Class A ordinary shares issued in connection with our initial business
combination, including, but not limited to, a private placement of equity or debt. Due to this anti-dilution feature of our founder shares, the founder shares and Class A ordinary shares issuable in connection with the conversion of the
founder shares may result in material dilution to our public shareholders due to the nominal price of $0.004 per founder share at which our sponsor purchased the founder shares and/or the anti-dilution rights of our founder shares that may
result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion. Our sponsor, directors and officers and their affiliates may receive additional compensation and/or may be issued additional securities in
connection with an initial business combination, including securities that may result in material dilution to public shareholders. For more information also see below under “ —Payments to insiders”
and “—Additional financing.”
|
| (2) |
The $10.00 per private placement unit conversion price for such working capital loans may potentially be significantly less than the market price of our shares at the time the lenders elect to convert their working capital loans into
private placement units. Further, the $11.50 exercise price of the private placement warrants included in the private placement units issuable upon conversion of working capital loans may be significantly less than the market price of our
shares at the time such private placement warrants are exercised. Similarly, depending on the market price of our shares at the time our private placement warrants are exercised, the cashless exercise feature of our private placement
warrants may also result in material dilution to our public shareholders given that the cashless exercise of the warrants will not result in any cash proceeds to us and holders of our private placement warrants would pay the private
placement warrant exercise price by surrendering their warrants for a number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied
by the excess of the “fair market value” (as defined immediately below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the Class A ordinary
shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. Therefore, such private placement unit issuances may result in significant dilution to
holders of our shares. For more information also see “Item 1A. Risk Factor—Risks Relating to our Search for, Consummation of, or Inability to Consummate, a Business Combination—We may issue shares to
investors in connection with our initial business combination at a price which is less than $10.00 or the prevailing market price of our shares at that time, which could dilute the interests of our existing shareholders and add costs” and
“Item 1A. Risk Factors—Risks Relating to our Sponsor and Management Team—Our warrants may have an adverse effect on the market price of our Class A ordinary shares and make it more difficult to effectuate our initial business combination.”
|
| (3) |
For more information, also see “ —Sources of Target Businesses,” “Item 11. Executive Compensation” and “Item 13. Certain Relationships and Related Transactions, and Director Independence.”
|
| • |
payment for office space, secretarial and administrative services by our sponsor, in the amount of $25,000 per month;
|
| • |
reimbursement for any out-of-pocket expenses related to identifying, investigating, negotiating and completing an initial business combination; and
|
| • |
repayment of loans which may be made by our sponsor, affiliates of our sponsor or our officers and directors to finance transaction costs in connection with an intended initial business combination. Up to $1,500,000 of such loans may be
convertible into private placement units of the post business combination entity at a price of $10.00 per unit at the option of the lender. The private placement units issued upon conversion of any such loans would be identical to the
private placement units sold in the private placement in connection with our initial public offering. Except for the foregoing, the terms of such loans, if any, have not been determined and no written agreements exist with respect to such
loans.
|
| • |
subject us to negative economic, competitive and regulatory developments, any or all of which may have a substantial adverse impact on the particular industry in which we operate after our initial business combination; and
|
| • |
cause us to depend on the marketing and sale of a single product or limited number of products or services.
|
| • |
we issue (other than in a public offering for cash) Class A ordinary shares that will either (a) be equal to or in excess of 20% of the number of Class A ordinary shares then issued and outstanding or (b) have voting power equal to or in
excess of 20% of the voting power then issued and outstanding;
|
| • |
any of our directors, officers or substantial shareholders (as defined by Nasdaq rules) has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly, in the target business or assets
to be acquired or otherwise and the present or potential issuance of ordinary shares could result in an increase in issued and outstanding ordinary shares or voting power of 5% or more; or
|
| • |
the issuance or potential issuance of ordinary shares will result in our undergoing a change of control.
|
| • |
the timing of the transaction, including in the event we determine shareholder approval would require additional time and there is either not enough time to seek shareholder approval or doing so would place the Company at a disadvantage
in the transaction or result in other additional burdens on the Company;
|
| • |
the expected cost of holding a shareholder vote;
|
| • |
the risk that the shareholders would fail to approve the proposed business combination;
|
| • |
other time and budget constraints of the Company; and
|
| • |
additional legal complexities of a proposed business combination that would be time-consuming and burdensome to present to shareholders.
|
| • |
Our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, directors, officers, advisors and their affiliates may purchase public shares from public
shareholders outside the redemption process, along with the purpose of such purchases;
|
| • |
if our sponsor, directors, officers, advisors and their affiliates were to purchase public shares from public shareholders, they would do so at a price no higher than the price offered through our redemption process;
|
| • |
our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by our sponsor, directors, officers, advisors and their affiliates would not be
voted in favor of approving the business combination transaction;
|
| • |
our sponsor, directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and
|
| • |
we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items:
|
| o |
the amount of our securities purchased outside of the redemption offer by our sponsor, directors, officers, advisors and their affiliates, along with the purchase price;
|
| o |
the purpose of the purchases by our sponsor, directors, officers, advisors and their affiliates;
|
| o |
the impact, if any, of the purchases by our sponsor, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved;
|
| o |
the identities of our security holders who sold to our sponsor, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to our
sponsor, directors, officers, advisors and their affiliates; and
|
| o |
the number of our securities for which we have received redemption requests pursuant to our redemption offer.
|
| • |
conduct the redemptions in conjunction with a proxy solicitation pursuant to Regulation 14A of the Exchange Act, which regulates the solicitation of proxies, and not pursuant to the tender offer rules; and
|
| • |
file proxy materials with the SEC.
|
| • |
conduct the redemptions pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, which regulate issuer tender offers; and
|
| • |
file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other information about the initial business combination and the redemption rights as is
required under Regulation 14A of the Exchange Act, which regulates the solicitation of proxies.
|
|
REDEMPTIONS IN
CONNECTION WITH OUR
INITIAL BUSINESS
COMBINATION
|
OTHER PERMITTED
PURCHASES OF PUBLIC
SHARES BY OUR
AFFILIATES
|
REDEMPTIONS IF WE FAIL
TO COMPLETE AN INITIAL
BUSINESS COMBINATION
|
||||
|
Calculation of redemption price
|
Redemptions at the time of our initial business combination may be made pursuant to a tender offer or in connection with a shareholder vote. The redemption price will be the same whether we conduct redemptions pursuant to a tender offer
or in connection with a shareholder vote. In either case, our public shareholders may redeem their public shares for cash equal to the aggregate amount then on deposit in the trust account calculated as of two business days prior to the
consummation of the initial business combination (which is initially anticipated to be $10.00 per share), including interest earned on the funds held in the trust account and not previously released to us for permitted withdrawals, if any,
divided by the number of the then-outstanding public shares, subject to any limitations (including but not limited to cash requirements) agreed to in connection with the negotiation of terms of a proposed business combination.
|
If we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors or their affiliates may purchase units, public shares or warrants in privately negotiated transactions or in the open market
either prior to or following completion of our initial business combination. There is no limit to the prices that our sponsor, directors, officers, advisors or their affiliates may pay in these transactions. If they engage in such
transactions, they will be restricted from making any such purchases when they are in possession of any material nonpublic information not disclosed to the seller or if such purchases are prohibited by Regulation M under the Exchange Act.
We do not currently anticipate that such purchases, if any, would constitute a tender offer subject to the tender offer rules under the Exchange Act or a going private transaction subject to the going-private rules under the Exchange Act;
however, if the purchasers determine at the time of any such purchases that the purchases are subject to such rules, the purchasers will be required to comply with such rules.
|
If we do not consummate an initial business combination within 24 months from the closing of our initial public offering, we will redeem all public shares at a per-share price, payable in cash, equal to the aggregate amount, then on
deposit in the trust account (which is initially anticipated to be $10.00 per share), including interest earned on the funds held in the trust account and not previously released to us for permitted withdrawals (less up to $100,000 of
interest to pay dissolution expenses) divided by the number of then issued and outstanding public shares.
|
|
Impact to remaining shareholders
|
The redemptions in connection with our initial business combination will reduce the book value per share for our remaining shareholders, who will bear the burden of the deferred underwriting commissions and permitted withdrawals.
|
If the permitted purchases described above are made, there would be no impact to our remaining shareholders because the purchase price would not be paid by us.
|
The redemption of our public shares if we fail to complete our initial business combination will reduce the book value per share for the shares held by our sponsor, who will be our only remaining shareholder after such redemptions.
|
| • |
may significantly dilute the equity interest of investors in our initial public offering, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on
a greater than one-to-one basis upon conversion of the Class B ordinary shares;
|
| • |
may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded to Class A ordinary shares;
|
| • |
could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, the post-business combination company’s ability to use its net operating loss carry forwards, if any,
and could result in the resignation or removal of officers and directors;
|
| • |
may have the effect of delaying or preventing a change of control of the post-business combination company by diluting the share ownership or voting rights of a person seeking to obtain control of the post-business combination company;
|
| • |
may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and
|
| • |
may not result in adjustment to the exercise price of our warrants.
|
| • |
default and foreclosure on the assets of the post-business combination company if its operating revenues are insufficient to repay its debt obligations;
|
| • |
acceleration of the post-business combination company’s obligations to repay such indebtedness, even if it makes all principal and interest payments when due, if it breaches certain covenants that require the maintenance of certain
financial ratios or reserves without a waiver or renegotiation of that covenant;
|
| • |
the post-business combination company’s immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
|
| • |
the post-business combination company’s inability to obtain necessary additional financing if the debt security contains covenants restricting its ability to obtain such financing while the debt security is outstanding;
|
| • |
using a substantial portion of the post-business combination company’s cash flow to pay principal and interest on its debt, which will reduce the funds available for expenses, capital expenditures, acquisitions and other general
corporate purposes;
|
| • |
limitations on the post-business combination company’s flexibility in planning for and reacting to changes in its business and in the industry in which it operates;
|
| • |
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
|
| • |
limitations on the post-business combination company’s ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of its strategy and other purposes and other disadvantages
compared to its competitors who have less debt.
|
| • |
We are a blank check company with no operating history and no revenues, and you have no basis on which to evaluate our ability to achieve our business objective. Until we complete our initial business combination, we will have no
operations and will generate no operating revenues.
|
| • |
Our public shareholders may not be afforded an opportunity to vote on our proposed initial business combination, and even if we hold a vote, holders of our founder shares will participate in such vote, which means we may complete our
initial business combination even though a majority of our public shareholders do not support such a combination.
|
| • |
Your only opportunity to effect your investment decision regarding a potential business combination may be limited to the exercise of your right to redeem your shares from us for cash.
|
| • |
If we seek shareholder approval of our initial business combination, our sponsor and members of our management team have agreed to vote in favor of such initial business combination, regardless of how our public shareholders vote.
|
| • |
The ability of our public shareholders to redeem their shares for cash may make our financial condition unattractive to potential business combination targets, which may make it difficult for us to enter into a business combination with
a target.
|
| • |
The ability of our public shareholders to exercise redemption rights with respect to a large number of our shares and the amount of deferred underwriting compensation may not allow us to complete the most desirable business combination
or optimize our capital structure, and may substantially dilute your investment in us.
|
| • |
The requirement that we consummate an initial business combination within 24 months after the closing of our initial public offering may give potential target businesses leverage over us in negotiating a business combination and may
limit the time we have to conduct due diligence on potential business combination targets, in particular as we approach our dissolution deadline, which could undermine our ability to complete our initial business combination on terms that
would produce value for our shareholders.
|
| • |
We may not be able to complete our initial business combination within 24 months from the closing of our initial public offering, in which case we would cease all operations except for the purpose of winding up and we would redeem our
public shares and liquidate. Our warrants will expire without value to the holder if we do not complete our initial business combination within the timeframe required by our amended and restated memorandum and articles of association.
|
| • |
If we seek shareholder approval of our initial business combination, our sponsor, directors, officers, advisors and their affiliates may elect to purchase shares or warrants from public shareholders, which may influence a vote on a
proposed business combination and reduce the public “float” of our Class A ordinary shares or warrants.
|
| • |
If a shareholder fails to receive notice of our offer to redeem our public shares in connection with our initial business combination, or fails to comply with the procedures for submitting or tendering its shares, such shares may not be
redeemed.
|
| • |
Because of our limited resources and the significant competition for business combination opportunities, it may be more difficult for us to complete our initial business combination. If we do not to complete our initial business
combination, our public shareholders may receive only their pro rata portion of the funds in the trust account that are available for distribution to public shareholders.
|
| • |
If the net proceeds of our initial public offering and the sale of the private placement units not being held in the trust account are insufficient to allow us to operate for at least the next 24 months, it could limit the amount
available to fund our search for a target business or businesses and complete our initial business combination, and we will depend on permitted withdrawals or loans from our sponsor or management team to fund our search and to complete our
initial business combination.
|
| • |
Past experience or performance by our management team or their affiliates may not be indicative of future performance of an investment in us.
|
| • |
You will not have any rights or interests in funds from the trust account, except under certain limited circumstances. Therefore, to liquidate your investment, you may be forced to sell your public shares or warrants, potentially at a
loss.
|
| • |
We may amend the terms of the warrants in a manner that may be adverse to holders of public warrants with the approval by the holders of at least 50% of the then-outstanding public warrants. As a result, the exercise price of your
warrants could be increased, the warrant could be converted into cash or shares (at a ratio different than initially provided), the exercise period could be shortened and the number of our Class A ordinary shares purchasable upon exercise
of a warrant could be decreased, all without your approval.
|
| • |
We may redeem your unexpired warrants prior to their exercise at a time that is disadvantageous to you, thereby making your warrants worthless.
|
| • |
Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions.
|
| • |
The nominal purchase price paid by our sponsor for the founder shares may result in significant dilution to the implied value of your public shares upon the consummation of our initial business combination.
|
| • |
We may be a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to U.S. investors.
|
| • |
Because we are incorporated in the Cayman Islands, you may face difficulties in protecting your interests, and your ability to protect your rights through the U.S. Federal courts may be limited.
|
| • |
Our officers, directors, security holders and their respective affiliates may have competitive pecuniary interests that conflict with our interests.
|
|
Public shares included in public units(1)
|
23,000,000
|
|||
|
Founder shares
|
5,750,000
|
|||
|
Private placement shares included in private placement units
|
660,000
|
|||
|
Total shares
|
29,410,000
|
|||
|
Total funds in trust at closing of initial public offering and available for initial
business combination(2)
|
$
|
230,000,000
|
||
|
Implied value per share
|
$
|
7.82
|
||
|
Sponsor’s average investment per share(3)
|
$
|
0.70
|
| (1) |
While the public shareholders’ investment is in both the public shares and the public warrants, for purposes of this table the full investment amount is ascribed to the public shares only.
|
| (2) |
Does not take into account other potential impacts on our valuation at the time of the business combination, such as the trading price of our public shares, interest accrued on any funds deposited in connection with the closing of the
initial public offering, the business combination transaction costs (including payment of $9,200,000 of deferred underwriting commissions), any equity issued or cash paid to the target’s sellers or other third parties, or the target’s
business itself, including its assets, liabilities, management and prospects.
|
| (3) |
The sponsor’s total investment in the equity of the Company, inclusive of the founder shares and the sponsor’s $4,300,000 investment in the private placement units, is $4,325,000.
|
| • |
Our registration statement/proxy statement filed for our business combination transaction would disclose the possibility that our sponsor, directors, officers, advisors and their affiliates may purchase public shares from public
shareholders outside the redemption process, along with the purpose of such purchases;
|
| • |
if our sponsor, directors, officers, advisors and their affiliates were to purchase public shares from public shareholders, they would do so at a price no higher than the price offered through our redemption process;
|
| • |
our registration statement/proxy statement filed for our business combination transaction would include a representation that any of our securities purchased by our sponsor, directors, officers, advisors and their affiliates would not be
voted in favor of approving the business combination transaction;
|
| • |
our sponsor, directors, officers, advisors and their affiliates would not possess any redemption rights with respect to our securities or, if they do acquire and possess redemption rights, they would waive such rights; and
|
| • |
we would disclose in a Form 8-K, before our security holder meeting to approve the business combination transaction, the following material items:
|
| o |
the amount of our securities purchased outside of the redemption offer by our sponsor, directors, officers, advisors and their affiliates, along with the purchase price;
|
| o |
the purpose of the purchases by our sponsor, directors, officers, advisors and their affiliates;
|
| o |
the impact, if any, of the purchases by our sponsor, directors, officers, advisors and their affiliates on the likelihood that the business combination transaction will be approved;
|
| o |
the identities of our security holders who sold to our sponsor, directors, officers, advisors and their affiliates (if not purchased on the open market) or the nature of our security holders (e.g., 5% security holders) who sold to our
sponsor, directors, officers, advisors and their affiliates; and
|
| o |
the number of our securities for which we have received redemption requests pursuant to our redemption offer.
|
| • |
being subject to complex laws and regulations, including environmental regulations, international safety regulations and vessel requirements imposed by classification societies that could require significant expenditures or subject us to
increased liability, and could adversely affect the cost, manner or feasibility of doing business;
|
| • |
increased inspection procedures and tighter import and export controls could increase costs and disrupt business;
|
| • |
damage to vessels;
|
| • |
failure to comply with the U.S. Foreign Corrupt Practices Act and other anti-corruption laws which could result in fines, criminal penalties, charter terminations and an adverse effect on a target business;
|
| • |
arrests of vessels by maritime claimants which could cause a significant loss of earnings for the related off-hire period;
|
| • |
labor interruptions;
|
| • |
smuggling of drugs or other contraband onto vessels which could lead to governmental claims;
|
| • |
governments could requisition vessels during a period of war or emergency, resulting in loss of earnings;
|
| • |
fuel or bunker prices and marine fuel availability could adversely affect profitability;
|
| • |
operating results may be subject to seasonal fluctuations; and
|
| • |
a target business with assets operating worldwide within the crude oil and oil products shipping sector, which is volatile and unpredictable, could experience risks including, but not limited to, a global and local market presence
impacting widespread operations, and being exposed to regulatory, statutory, operational, technical, counterparty, environmental, and political risks, developments and regulations that may impact and/or disrupt our business.
|
| • |
an inability to compete effectively in a highly competitive environment with many incumbents having substantially greater resources;
|
| • |
an inability to manage rapid change, increasing customer expectations and growth;
|
| • |
a reliance on proprietary technology to provide services and to manage our operations, and the failure of this technology to operate effectively, or our failure to use such technology effectively;
|
| • |
an inability to deal with our customers’ privacy concerns;
|
| • |
an inability to attract and retain customers;
|
| • |
an inability to license or enforce intellectual property rights on which our business may depend;
|
| • |
any significant disruption in our computer systems or those of third parties that we would utilize in our operations;
|
| • |
potential liability for negligence, copyright, or trademark infringement or other claims based on the nature and content of materials that we may distribute;
|
| • |
disruption or failure of our networks, systems or technology as a result of computer viruses, “cyber-attacks,” misappropriation of data or other malfeasance, as well as outages, natural disasters, terrorist attacks, accidental releases
of information or similar events;
|
| • |
an inability to obtain necessary hardware, software and operational support; supply-chain constraints affecting semiconductors, specialized hardware, or critical raw materials may extend production lead times, elevate costs, or
necessitate design modifications, thereby impairing our ability to satisfy contractual delivery milestones and potentially triggering liquidated damages clauses;
|
| • |
reliance on third-party vendors or service providers; and
|
| • |
our business may be subject to extensive government regulations in the markets in which we will operate, any of which may be difficult and expensive to comply with such as rapidly evolving regulatory frameworks governing data privacy,
cybersecurity, artificial intelligence, and critical digital infrastructure, both in the United States and in key foreign jurisdictions; changes to those regulations could increase our costs.
|
| • |
may significantly dilute the equity interest of our investors, which dilution would increase if the anti-dilution provisions in the Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one
basis upon conversion of the Class B ordinary shares;
|
| • |
may subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded to Class A ordinary shares;
|
| • |
could cause a change in control if a substantial number of Class A ordinary shares are issued, which may affect, among other things, the post-business combination company’s ability to use its net operating loss carry forwards, if any,
and could result in the resignation or removal of officers and directors;
|
| • |
may have the effect of delaying or preventing a change of control of the post-business combination company by diluting the share ownership or voting rights of a person seeking to obtain control of the post-business combination company;
|
| • |
may adversely affect prevailing market prices for our units, Class A ordinary shares and/or warrants; and
|
| • |
may not result in adjustment to the exercise price of our warrants.
|
| • |
default and foreclosure on the assets of the post-business combination company if its operating revenues are insufficient to repay its debt obligations;
|
| • |
acceleration of the post-business combination company’s obligations to repay such indebtedness, even if it makes all principal and interest payments when due, if it breaches certain covenants that require the maintenance of certain
financial ratios or reserves without a waiver or renegotiation of that covenant;
|
| • |
the post-business combination company’s immediate payment of all principal and accrued interest, if any, if the debt security is payable on demand;
|
| • |
the post-business combination company’s inability to obtain necessary additional financing if the debt security contains covenants restricting its ability to obtain such financing while the debt security is outstanding;
|
| • |
using a substantial portion of the post-business combination company’s cash flow to pay principal and interest on its debt, which will reduce the funds available for expenses, capital expenditures, acquisitions and other general
corporate purposes;
|
| • |
limitations on the post-business combination company’s flexibility in planning for and reacting to changes in its business and in the industry in which it operates;
|
| • |
increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and
|
| • |
limitations on the post-business combination company’s ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of its strategy and other purposes and other disadvantages
compared to its competitors who have less debt.
|
| • |
solely dependent upon the performance of a single business, property or asset; or
|
| • |
dependent upon the development or market acceptance of a single or limited number of products, processes or services.
|
| • |
restrictions on the nature of our investments; and
|
| • |
restrictions on the issuance of securities, each of which may make it difficult for us to complete our initial business combination. In addition, we may have imposed upon us burdensome requirements, including:
|
| • |
registration as an investment company with the SEC;
|
| • |
adoption of a specific form of corporate structure; and
|
| • |
reporting, record keeping, voting, proxy and disclosure requirements and other rules and regulations that we are currently not subject to.
|
| • |
a limited availability of market quotations for our securities;
|
| • |
reduced liquidity for our securities;
|
| • |
a determination that our Class A ordinary shares are a “penny stock” which will require brokers trading in our Class A ordinary shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the
secondary trading market for our securities;
|
| • |
a limited amount of news and analyst coverage; and
|
| • |
a decreased ability to issue additional securities or obtain additional financing in the future.
|
| • |
we have a board that includes a majority of “independent directors,” as defined under Nasdaq rules;
|
| • |
we have a compensation committee of our board that is comprised entirely of independent directors with a written charter addressing the committee’s purpose and responsibilities; and
|
| • |
we have independent director oversight of our director nominations.
|
| • |
costs and difficulties inherent in managing cross-border business operations;
|
| • |
rules and regulations regarding currency redemption;
|
| • |
complex corporate withholding taxes on individuals;
|
| • |
laws governing the manner in which future business combinations may be effected;
|
| • |
exchange listing and/or delisting requirements;
|
| • |
tariffs and trade barriers;
|
| • |
regulations related to customs and import/export matters;
|
| • |
local or regional economic policies and market conditions;
|
| • |
unexpected changes in regulatory requirements;
|
| • |
longer payment cycles;
|
| • |
tax issues, such as tax law changes and variations in tax laws as compared to the United States;
|
| • |
currency fluctuations and exchange controls;
|
| • |
rates of inflation;
|
| • |
challenges in collecting accounts receivable;
|
| • |
cultural and language differences;
|
| • |
employment regulations;
|
| • |
underdeveloped or unpredictable legal or regulatory systems;
|
| • |
corruption;
|
| • |
protection of intellectual property;
|
| • |
social unrest, crime, strikes, riots and civil disturbances;
|
| • |
regime changes and political upheaval;
|
| • |
terrorist attacks, natural disasters, widespread health emergencies and wars; and
|
| • |
deterioration of political relations with the United States.
|
| Item 4. | Mine Safety Disclosures |
|
Item 5.
|
Market for Registrant’s Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities
|
| (a) |
Market Information
|
| (b) |
Holders
|
| (c) |
Dividends
|
| (d) |
Securities Authorized for Issuance under Equity Compensation Plans
|
| (e) |
Performance Graph
|
| (f) |
Recent Sales of Unregistered Securities; Use of Proceeds from Registered Offerings
|
| (g) |
Purchases of Equity Securities by the Issuer and Affiliated Purchasers
|
|
Item 7.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
|
December 4,
2025
|
||||
|
Implied ordinary share price
|
$
|
9.82
|
||
|
Exercise price
|
$
|
11.50
|
||
|
Simulation term (years)
|
7.00
|
|||
|
Risk-free rate
|
3.87
|
%
|
||
|
Estimated implied volatility
|
2.10
|
%
|
||
|
Market adjustment
|
32.19
|
%
|
||
|
Calculated value per warrant
|
$
|
0.34
|
||
|
Report of Independent Registered Public Accounting Firm
|
F-2
|
|
Financial Statements:
|
|
|
Balance Sheet
|
F-3
|
|
Statement of Operations
|
F-4
|
|
Statement of Changes in Shareholders’ Deficit
|
F-5
|
|
Statement of Cash Flows
|
F-6
|
|
Notes to Financial Statements
|
F-7 to F-20
|
| Item 10. |
Directors, Executive Officers and Corporate Governance
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
Peter C. Georgiopoulos
|
|
65
|
|
Chairman, Chief Executive Officer and Director
|
|
Leonard Vrondissis
|
|
48
|
|
President and Director
|
|
Stewart Crawford
|
|
52
|
|
Chief Financial Officer
|
|
Alexandros Argyros
|
|
45
|
|
Director
|
|
Chele Farley
|
|
59
|
|
Director
|
|
Warren Hosseinion
|
|
53
|
|
Director
|
|
Jonathan Intrater
|
|
68
|
|
Director
|
| • |
meeting with our independent registered public accounting firm regarding, among other issues, audits, and adequacy of our accounting and control systems;
|
| • |
monitoring the independence of the independent registered public accounting firm;
|
| • |
verifying the rotation of the lead (or coordinating) audit partner having primary responsibility for the audit and the audit partner responsible for reviewing the audit as required by law;
|
| • |
inquiring and discussing with management our compliance with applicable laws and regulations;
|
| • |
pre-approving all audit services and permitted non-audit services to be performed by our independent registered public accounting firm, including the fees and terms of the services to be performed;
|
| • |
appointing or replacing the independent registered public accounting firm;
|
| • |
determining the compensation and oversight of the work of the independent registered public accounting firm (including resolution of disagreements between management and the independent auditor regarding financial reporting) for the
purpose of preparing or issuing an audit report or related work;
|
| • |
establishing procedures for the receipt, retention and treatment of complaints received by us regarding accounting, internal accounting controls or reports which raise material issues regarding our financial statements or accounting
policies;
|
| • |
monitoring compliance on a quarterly basis with the terms of our initial public offering and, if any noncompliance is identified, immediately taking all action necessary to rectify such noncompliance or otherwise causing compliance
with the terms of our initial public offering; and
|
| • |
reviewing and approving all payments made to our existing shareholders, officers or directors and their respective affiliates. Any payments made to members of our audit committee will be reviewed and approved by our board of directors,
with the interested director or directors abstaining from such review and approval.
|
| • |
should have demonstrated notable or significant achievements in business, education or public service;
|
| • |
should possess the requisite intelligence, education and experience to make a significant contribution to the board of directors and bring a range of skills, diverse perspectives and backgrounds to its deliberations; and
|
| • |
should have the highest ethical standards, a strong sense of professionalism and intense dedication to serving the interests of the shareholders.
|
| • |
reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and
determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation;
|
| • |
reviewing and approving the compensation of all of our other Section 16 officers;
|
| • |
reviewing our executive compensation policies and plans;
|
| • |
implementing and administering our incentive compensation equity-based remuneration plans;
|
| • |
assisting management in complying with our proxy statement and annual report disclosure requirements;
|
| • |
approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees;
|
| • |
producing a report on executive compensation to be included in our annual proxy statement; and
|
| • |
reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors.
|
| • |
duty to act in good faith in what the director or officer believes to be in the best interests of the Company as a whole;
|
| • |
duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose;
|
| • |
directors should not improperly fetter the exercise of future discretion;
|
| • |
duty to exercise authority for the purpose for which it is conferred and a duty to exercise powers fairly as between different sections of shareholders;
|
| • |
duty not to put themselves in a position in which there is a conflict between their duty to the Company and their personal interests; and
|
| • |
duty to exercise independent judgment.
|
|
INDIVIDUAL
|
|
ENTITY
|
|
ENTITY’S BUSINESS
|
|
AFFILIATION
|
|
Peter Georgiopoulos
|
|
United Overseas Group
|
|
Provider of maritime transportation services
|
|
Chairman and President
|
|
|
Quantum HPC
|
|
High-performance mission critical facilities
|
|
Chairman and Director
|
|
|
|
SeaArctos
|
|
Emissions tracking for shipping
|
|
Chairman and Director
|
|
|
|
IGP Methanol
|
|
Decarbonization of chemicals and fuels
|
|
Director
|
|
|
|
PaymentWorks
|
|
Secure automated vendor onboarding and payments
|
|
Director
|
|
|
|
|
|
||||
|
Leonard Vrondissis
|
|
United Overseas Group
|
|
Provider of maritime transportation services
|
|
Secretary and Director
|
|
|
Quantum HPC
|
|
High-performance mission critical facilities
|
|
Director
|
|
|
|
SeaArctos
|
|
Emissions tracking for shipping
|
|
Director
|
|
|
|
IGP Methanol
|
|
Decarbonization of chemicals and fuels
|
|
Director
|
|
|
|
|
|
||||
|
Stewart Crawford
|
|
United Overseas Group
|
|
Provider of maritime transportation services
|
|
Chief Financial Officer
|
|
|
|
|
||||
|
Alexandros Argyros
|
|
AXIA Ventures Group
|
|
Investment bank
|
|
Director, Managing Director and Head of Investment Banking
|
| Alpha Finance |
Investment bank
|
Director | ||||
|
Chele Farley
|
|
Mistral Capital International
|
|
Private equity fund
|
|
Partner and Managing Director
|
|
|
CDT Equity
|
|
Clinical-stage biopharmaceuticals
|
|
Director
|
|
|
|
Palmilla San Jose Inmobiliara
|
|
Real estate resort development
|
|
Director
|
|
|
|
|
|
||||
|
Warren Hosseinion
|
|
Voyager Acquisition Corp
|
|
SPAC
|
|
Chairman
|
|
|
Nutex Health, Inc.
|
|
Healthcare services and operations
|
|
Director and President
|
|
|
|
Cardio Diagnostics Holdings, Inc.
|
|
Provider of AI-driven tests to detect and manage heart disease
|
|
Chairman
|
|
|
|
|
|
||||
|
Jonathan Intrater
|
|
Ladenburg Thalmann
|
|
Investment bank
|
|
Managing Director
|
|
|
Voyager Acquisition Corp
|
|
SPAC
|
|
Director
|
| • |
Our officers and directors are not required to, and will not, commit their full time to our affairs, which may result in a conflict of interest in allocating their time between our operations and our
search for a business combination and their other businesses. We do not intend to have any full-time employees prior to the completion of our initial business combination. Each of our officers is engaged in several other business
endeavors for which he may be entitled to substantial compensation, and our officers are not obligated to contribute any specific number of hours per week to our affairs. Further, our sponsor and our officers and directors may sponsor
or form other SPACs similar to ours or may pursue other business or investment ventures during the period in which we are seeking an initial business combination. Any such companies, businesses or investments may present additional
conflicts of interest in pursuing an initial business combination. However, we do not believe that any such potential conflicts would materially affect our ability to complete our initial business combination.
|
| • |
Our sponsor subscribed for founder shares and purchased private placement units in a transaction that closed simultaneously with the closing of our initial public offering. Our sponsor and our
management team and the underwriters have entered into an agreement with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares included in any private
placement units and public shares in connection with (i) the completion of our initial business combination and (ii) the implementation by the directors of, following a shareholder vote to approve, an amendment to our amended and
restated memorandum and articles of association (A) to modify the substance or timing of our obligation to provide holders of our Class A ordinary shares the right to have their shares redeemed in connection with our initial business
combination or to redeem 100% of our public shares if we do not complete our initial business combination within 24 months from the closing of our initial public offering or (B) with respect to any other material provision relating to
the rights of holders of our Class A ordinary shares. Additionally, our sponsor and each member of our management team and the underwriters have agreed to waive their rights to liquidating distributions from the trust account with
respect to their founder shares and their private placement units if we fail to complete our initial business combination within the required time period. Except as described herein, our sponsor and our management team and the
underwriters have agreed not to transfer, assign or sell any of their founder shares until the earlier of (A) one year following the completion of our initial business combination and (B) subsequent to the completion of our initial
business combination, the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the right to exchange their ordinary shares for
cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations,
recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 180 days after the completion of our initial business combination, the founder shares will be released from the lock-up. With
certain limited exceptions, the private placement units (and any private placement share or private placement warrant included in such private placement units) will not be transferable until 30 days following the completion of our
initial business combination. Except as described herein, our sponsor, directors and officers and the underwriters also agreed not to transfer any of their securities until May 31, 2026 (or 180 days following the pricing of our
initial public offering on December 2, 2025). For more information on the letter agreement in which the transfer restrictions are included and for more information on the limited exceptions to such
transfer restrictions, also see “Item 1. Business—Initial Business Combination.” Because each of our officers and directors owns ordinary shares and/or
private placement units (including their underlying securities) directly or indirectly, they may have a conflict of interest in determining whether a particular target business is an appropriate business with which to effectuate our
initial business combination.
|
| • |
Our officers and directors may have a conflict of interest with respect to evaluating a particular business combination if the retention or resignation of any such officers and directors was included
by a target business as a condition to any agreement with respect to our initial business combination. The low price that our sponsor, officers and directors (directly or indirectly) paid for the founder shares creates an incentive
whereby our officers and directors could potentially make a substantial profit even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. If we do not complete our initial
business combination within 24 months from the closing of our initial public offering, the founder shares and private placement units held by our sponsor may lose most of their value, except to the extent that the founder shares or the
Class A ordinary shares included in the private placement units receive liquidating distributions from assets outside the trust account, which could create an incentive for our sponsor, officers and directors to complete a transaction
even if we select an acquisition target that subsequently declines in value and is unprofitable for public shareholders. Similarly, additional conflicts of interests may arise and incentives may be created to select an acquisition
target that subsequently declines in value and is unprofitable for public shareholders instead of not consummating a business combination if (i) after the redemption of public shareholders no assets are available outside of the trust
account to repay any loans extended to us by our sponsor, affiliates of our sponsor or our officers and directors and to reimburse our sponsor and others for any out-of-pocket expenses incurred in connection with identifying,
investigating and completing an initial business combination or (ii) not consummating a business combination within the allotted time may require service providers to forfeit their fees.
|
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
| • |
each person known by us to be the beneficial owner of more than 5% of each class of our issued and outstanding ordinary shares;
|
| • |
each of our executive officers and directors that beneficially owns our ordinary shares; and
|
| • |
all our executive officers and directors as a group.
|
|
Class B ordinary shares
|
Class A ordinary shares
|
Ordinary shares
|
||||||||||||||||||
|
Name of Beneficial Owners(1)
|
Number of Shares Beneficially Owned
|
Approximate Percentage of Class
|
Number of Shares Beneficially Owned
|
Approximate Percentage of Class
|
Approximate Percentage of Voting Control(2)
|
|||||||||||||||
|
Sponsor and Directors and Officers
|
||||||||||||||||||||
|
General Purpose Acquisition Corp Services LLC (our sponsor)(3)(4)
|
5,750,000
|
100.00
|
%
|
430,000
|
(8)
|
1.8
|
%
|
21.0
|
%
|
|||||||||||
|
Peter Georgiopoulos(4)(5)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Leonard Vrondissis(4)(5)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Stewart Crawford(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Alexandros Argyros(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Chele Farley(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Warren Hosseinion(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Jonathan Intrater(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
All officers and directors as a group (seven individuals)(4)(5)(6)
|
—
|
—
|
—
|
—
|
—
|
|||||||||||||||
|
Other 5% Holders
|
||||||||||||||||||||
|
Millennium Management LLC(7)
|
—
|
—
|
1,200,000
|
5.1
|
%
|
4.1
|
%
|
|||||||||||||
| (1) |
Unless otherwise noted, the business address of the following entities or individuals is 59 Front Street, Millbrook, New York 12545.
|
| (2) |
Assuming the automatic conversion of Class B ordinary shares into Class A ordinary shares at the time of the Company’s initial business combination. The Class B ordinary shares will automatically convert into Class A ordinary shares at
the time of our initial business combination or earlier at the option of the holder on a one-for-one basis (such Class A ordinary share delivered upon conversion will not have any redemption rights or be entitled to liquidating
distributions from the trust account if we fail to consummate an initial business combination), subject to adjustment pursuant to certain anti-dilution rights, as further described in this Annual Report.
|
| (3) |
As reported on the Schedule 13D filed on December 4, 2025, the sponsor is the record holder of 5,750,000 Class B ordinary shares and 430,000 private placement units, which include 430,000 private placement shares and 215,000 private
placement warrants. Our sponsor is organized in the Cayman Islands as a limited liability company for the purpose of holding securities in us and providing certain services to us pursuant to the administrative services and indemnification
agreement, as further described in this Annual Report. The co-managers of our sponsor are Peter Georgiopoulos and Leonard Vrondissis, each of whom may be deemed to beneficially own the reported
securities.
|
| (4) |
Due to their economic interest in our sponsor of approximately 70% and 30% respectively, each of Peter Georgiopoulos and Leonard Vrondissis may be considered to have a material interest in our sponsor.
|
| (5) |
Does not include any shares indirectly owned by this individual as a result of his direct or indirect ownership interest in our sponsor.
|
| (6) |
Does not include any shares indirectly owned by this individual as a result of his or her ownership interest in our sponsor. Stewart Crawford, our Chief
Financial Officer, and Alexandros Argyros, Chele Farley, Warren Hosseinion and Jonathan Intrater, our independent directors, received membership interests in our sponsor for their service as Chief Financial Officer and as a director,
respectively.
|
| (7) |
Represents Class A ordinary shares, which, pursuant to a Schedule 13G filed by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander on December 8, 2025 (the “Millenium Statement”), are reported as being
potentially beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Mr. Englander and are reported as being held by entities subject to voting control and investment discretion by Millennium Management LLC
and/or other investment managers that may be controlled by Millennium Group Management LLC (the managing member of Millennium Management LLC) and Mr. Englander (the sole voting trustee of the managing member of Millennium Group Management
LLC). The Millenium Statement should not be construed in and of itself as an admission by Millennium Management LLC, Millennium Group Management LLC or Mr. Englander as to beneficial ownership of the Class A ordinary shares held by such
entities. The business address of each of the foregoing entities, each of which are incorporated in Delaware, USA, is 399 Park Avenue, New York, New York 10022. The business address of Mr. Englander, a United States citizen, is c/o
Millennium Management LLC, 399 Park Avenue, New York, New York 10022.
|
| (8) |
Represents private placement shares included in the 430,000 private placement units purchased by the sponsor in connection with the consummation of the initial public offering, as further described in this Annual Report.
|
| • |
1% of the total number of ordinary shares then outstanding, which will equal to 294,100 shares as of the date of this Annual Report; and
|
| • |
the average weekly reported trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.
|
| • |
the issuer of the securities that was formerly a shell company has ceased to be a shell company;
|
| • |
the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;
|
| • |
the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials),
other than Form 8-K reports; and
|
| • |
at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.
|
|
SUBJECT SECURITIES
|
TRANSFER RESTRICTIONS
|
NATURAL PERSONS AND ENTITIES SUBJECT TO TRANSFER RESTRICTIONS
|
EXCEPTIONS TO TRANSFER RESTRICTIONS
|
||||
|
Founder Shares (1)(2)
|
Agreement not to (a) sell, offer to sell, contract or agree to sell, hypothecate, pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase a put equivalent
position or liquidation with respect to or decrease a call equivalent position within the meaning of Section 16 of the Exchange Act and the rules and regulations of the SEC promulgated thereunder with respect to, any security, (b) enter
into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or
otherwise, or (c) publicly announce any intention to effect any transaction specified in clause (a) or (b) (each of the foregoing, a “Transfer”), until the earlier of (A) one year following the completion of our initial business
combination and (B) subsequent to our initial business combination, the date on which we complete a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of our public shareholders having the
right to exchange their ordinary shares for cash, securities or other property. Notwithstanding the foregoing, if the last sale price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions,
share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 180 days after the completion of our initial business combination, the founder shares
will be released from the lock-up. Further, no Transfer of any Class A ordinary shares, Class B ordinary shares or any other securities convertible into, or exercisable or exchangeable for, ordinary shares until May 31, 2026 (or 180 days
following the pricing of our initial public offering on December 2, 2025). Certain transfer restrictions pursuant to FINRA rules may also apply to any securities deemed underwriting compensation.
|
Our sponsor, directors and officers
|
Restrictions are not applicable to transfers (a) to our officers or directors, any affiliates or family members of any of our officers or directors, any members or partners of our sponsor or their affiliates, any affiliates of our
sponsor, or any employees of such affiliates; (b) in the case of an individual, by gift to a member of one of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family, an
affiliate of such person or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic
relations order; (e) by private sales or transfers made in connection with the consummation of a business combination at prices no greater than the price at which the founder shares, private placement units, private placement warrants,
private placement shares or Class A ordinary shares, as applicable, were originally purchased; (f) pro rata distributions from our sponsor to its members, partners, or shareholders pursuant to our sponsor’s operating agreement, (g) by
virtue of our sponsor’s organizational documents upon liquidation or dissolution of our sponsor; (h) to the Company for no value for cancellation in connection with the consummation of our initial business combination; (i) in the event of
our liquidation prior to the completion of our initial business combination; or (j) in the event of our completion of a liquidation, merger, share exchange or other similar transaction which results in all of our public shareholders
having the right to exchange their Class A ordinary shares for cash, securities or other property subsequent to our completion of our initial business combination; provided, however, that in the
case of clauses (a) through (g) these permitted transferees must enter into a written agreement agreeing to be bound by these transfer restrictions and the other restrictions contained in the letter agreement. Any permitted transferees
would be subject to the same restrictions and other agreements of our sponsor and management team with respect to any founder shares and private placement units (including their underlying securities). Further, despite the 180 day
Transfer restriction after May 31, 2026 (or 180 days following the pricing of our initial public offering on December 2, 2025 that is described under the column “Transfer restrictions” to the left of this column), the underwriting
agreement authorizes registration with the SEC pursuant to the Registration Rights and Shareholder Rights Agreement of the resale of the founder shares, the private placement units (including any private placement units issued upon
conversion of working capital loans) and their underlying securities, the exercise of the private placement warrants and the public warrants and the Class A ordinary shares issuable upon exercise of such warrants or conversion of founder
shares.
|
||||
|
Private Placement Units and underlying securities (1)(2)
|
No Transfer until 30 days after the completion of our initial business combination. Further, no Transfer of any Class A ordinary shares, Class B ordinary shares or any other securities convertible into, or exercisable or exchangeable
for, ordinary shares until May 31, 2026 (or 180 days following the pricing of our initial public offering on December 2, 2025). Certain transfer restrictions pursuant to FINRA rules may also apply to any securities deemed underwriting
compensation.
|
Our sponsor, directors and officers
|
Same as above. FINRA rule 5110(e)(2) includes certain limited exemption to the transfer restrictions applicable to securities deemed underwriting compensation pursuant to FINRA Rule 5110.
|
| (1) |
For more information on the number securities beneficially held by our sponsor, please see the beneficial ownership table in above in this section “Item 12. Security Ownership of Certain Beneficial
Owners and Management and Related Stockholder Matters.”
|
| (2) |
The founder shares and private placement units, including any private placement shares and private placement warrants included in such private placement units, issued in connection or simultaneously with our initial public offering are
restricted securities and subject to the limitations on transfer described above under “ —Securities Eligible for Future Sale—Rule 144” and “ —Securities Eligible
for Future Sale—Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies.” Further, our sponsor, its permitted transferees or any other person that becomes an affiliate of the post-business combination
company for purposes of Rule 144 under the Securities Act may be subject to additional resale restrictions with respect to securities they hold, as described above.
|
| Item 13. |
Certain Relationships and Related Transactions, and Director Independence
|
| Item 14. |
Principal Accountant Fees and Services
|
| (a) |
The following documents are filed as part of this Annual Report:
|
|
(1)
|
Financial Statements
|
|
(2)
|
Financial Statement Schedules
|
|
(3)
|
Exhibits
|
|
Exhibit No.
|
Description
|
|
|
Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 of the Company’s Current Report on Form 8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Specimen Unit Certificate (incorporated by reference to Exhibit 4.1 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Specimen Warrant Certificate (incorporated by reference to Exhibit 4.3 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Warrant Agreement, dated December 2, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.1 of the Company’s Current Report on Form 8-K, filed
with the SEC on December 2, 4, 2025)
|
||
|
Description of Registrant’s Securities*
|
||
|
Letter Agreement, dated December 2, 2025, by and among the Company, its officers, its directors and General Purpose Acquisition Corp Services LLC (incorporated by reference to Exhibit 10.1 of
the Company’s Current Report on Form 8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Investment Management Trust Agreement, dated December 2, 2025, by and between the Company and Continental Stock Transfer & Trust Company, as trustee (incorporated by reference to Exhibit 10.2 of the Company’s Current Report on Form
8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Registration and Shareholder Rights Agreement, dated December 2, 2025, by and among the Company, General Purpose Acquisition Corp Services LLC and the Holders signatory thereto (incorporated by reference to Exhibit 10.3 of the
Company’s Current Report on Form 8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Private Placement Units Purchase Agreement, dated December 2, 2025, by and between the Company and General Purpose Acquisition Corp Services LLC (incorporated by reference to Exhibit 10.4 of the Company’s Current Report on Form 8-K,
filed with the SEC on December 2, 4, 2025)
|
||
|
Private Placement Units Purchase Agreement, dated December 2, 2025, by and between the Company and Jefferies LLC (incorporated by reference to Exhibit 10.5 of the Company’s Current Report on Form 8-K, filed with the SEC on December 2,
4, 2025)
|
||
|
Administrative Services and Indemnification Agreement, dated December 2, 2025, by and between the Company and General Purpose Acquisition Corp Services LLC (incorporated by reference to Exhibit 10.6 of the Company’s Current Report on
Form 8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Form of Indemnity Agreement (incorporated by reference to Exhibit 10.5 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Promissory Note, dated as of August 26, 2025, issued to the Sponsor (incorporated by reference to Exhibit 10.7 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Securities Subscription Agreement, dated August 11, 2025, between the Registrant and the Sponsor (incorporated by reference to Exhibit 10.8 to the Company’s Registration Statement on Form S-1, filed with the SEC on October 14, 2025)
|
||
|
Underwriting Agreement, dated December 2, 2025, by and between the Company and Jefferies LLC as representative of the underwriters (incorporated by reference to Exhibit 1.1 of the Company’s
Current Report on Form 8-K, filed with the SEC on December 2, 4, 2025)
|
||
|
Insider Trading Policy*
|
||
|
Subsidiaries of the Company*
|
||
|
Certification of the Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a)*
|
||
|
Certification of the Chief Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a)*
|
||
|
Certification of the Chief Executive Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**
|
||
|
Certification of the Chief Financial Officer required by Rule 13a-14(b) or Rule 15d-14(b) and 18 U.S.C. 1350**
|
||
|
Clawback Policy*
|
| * |
Filed herewith
|
| ** |
Furnished herewith.
|
|
GENERAL PURPOSE ACQUISITION CORP.
|
||
|
/s/ Peter Georgiopoulos
|
||
|
March 27, 2026
|
Name: Peter Georgiopoulos
|
|
|
Title: Chairman and Chief Executive Officer
|
|
Name
|
Position
|
Date
|
|||
| /s/ Peter Georgiopoulos |
Chairman of the Board of Directors and Chief Executive Officer
|
March 27, 2026
|
|||
|
Peter Georgiopoulos
|
(Principal Executive Officer)
|
|
|||
|
/s/ Stewart Crawford
|
Chief Financial Officer
|
March 27, 2026
|
|||
|
Stewart Crawford
|
(Principal Financial Officer and Principal Accounting Officer)
|
||||
|
/s/ Leonard Vrondissis
|
President and Director
|
March 27, 2026
|
|||
|
Leonard Vrondissis
|
|||||
|
/s/ Alexandros Argyros
|
Director
|
March 27, 2026
|
|||
|
Alexandros Argyros
|
|
/s/ Chele Farley
|
Director
|
March 27, 2026
|
|||
|
Chele Farley
|
|
/s/ Warren Hosseinion
|
Director
|
March 27, 2026
|
|||
|
Warren Hosseinion
|
|
/s/ Jonathan Intrater
|
Director
|
March 27, 2026
|
|||
|
Jonathan Intrater
|
|
F-2
|
|||
|
Financial Statements
|
|||
|
F-3
|
|||
|
F-4
|
|||
|
F-5
|
|||
|
F-6
|
|||
|
F-7 to F-20
|
|||
|
December 31,
|
||||
|
2025
|
||||
|
Assets:
|
||||
|
Current assets
|
||||
|
Cash
|
$
|
|
||
|
Prepaid expenses - current
|
|
|||
|
Total current assets
|
|
|||
|
Non-current assets
|
||||
|
Cash and marketable securities held in Trust Account
|
|
|||
|
Prepaid expenses – non-current
|
|
|||
|
Total non-current assets
|
|
|||
|
Total Assets
|
$
|
|
||
|
Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders’ Deficit:
|
||||
|
Current liabilities
|
||||
|
Accrued offering costs
|
$
|
|
||
|
Due to related party
|
||||
|
Accrued expenses
|
|
|||
|
Accounts payable
|
|
|||
|
Total current liabilities
|
|
|||
|
Non-current liabilities
|
||||
|
Deferred underwriting commissions
|
|
|||
|
Total non-current liabilities
|
|
|||
|
Total Liabilities
|
|
|||
|
Commitments and Contingencies (Note 7)
|
||||
| Class A ordinary shares subject to possible redemption, $ |
|
|||
|
Shareholders’ Deficit
|
||||
| Preference shares, $ |
|
|||
| Class A ordinary shares, $ |
|
|||
| Class B ordinary shares, $ |
|
|||
|
Additional paid-in capital
|
|
|||
|
Accumulated deficit
|
( |
)
|
||
|
Total Shareholders’ Deficit
|
( |
)
|
||
|
Total Liabilities, Class A Ordinary Shares Subject to Redemption, and Shareholders’ Deficit
|
$
|
|
||
|
For the Period
from July 25,
2025 (inception)
|
||||
|
through
|
||||
|
December 31, 2025
|
||||
|
Formation, general and administrative expenses
|
$
|
|
||
|
Loss from operations
|
( |
)
|
||
|
Other income:
|
||||
|
Income earned on cash and marketable securities held in Trust Account
|
|
|||
|
Other income, net
|
|
|||
|
Net income
|
$
|
|
||
|
Basic and diluted weighted average shares outstanding, Class A ordinary shares subject to possible redemption
|
|
|||
|
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption
|
$
|
|
||
|
Basic and diluted weighted average shares outstanding, non-redeemable Class A ordinary shares
|
|
|||
|
Basic and diluted net income per share, non-redeemable Class A ordinary shares
|
$
|
|
||
|
Basic weighted average shares outstanding, non-redeemable Class B ordinary shares
|
|
|||
|
Basic net income per share, non-redeemable Class B ordinary shares
|
$
|
|
||
|
Diluted weighted average shares outstanding, non-redeemable Class B ordinary shares
|
|
|||
|
Diluted net income per share, non-redeemable Class B ordinary shares
|
$
|
|
||
|
Class A Ordinary
Shares
|
Class B Ordinary
Shares
|
Additional
Paid-in
Capital
|
Accumulated
|
Total
Shareholders’ |
||||||||||||||||||||||||
|
Shares
|
Amount
|
Shares
|
Amount
|
Deficit
|
Deficit
|
|||||||||||||||||||||||
|
Balance – July 25, 2025 (inception)
|
|
$
|
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||||||
|
Class B ordinary shares issued to Sponsor
|
—
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Fair value of Public Warrants included in Public Units
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
|
Sale of Private Placement Units
|
|
|
—
|
|
|
|
|
|||||||||||||||||||||
|
Allocated value of transaction costs to warrants
|
—
|
|
—
|
|
( |
)
|
|
( |
)
|
|||||||||||||||||||
|
Remeasurement of Class A ordinary shares subject to possible redemption to redemption value
|
—
|
|
—
|
|
( |
)
|
( |
)
|
( |
)
|
||||||||||||||||||
|
Net income
|
—
|
|
—
|
|
|
|
|
|||||||||||||||||||||
|
Balance – December 31, 2025
|
|
$
|
|
|
$
|
|
$
|
|
$
|
( |
)
|
$
|
( |
)
|
||||||||||||||
|
Cash Flows from Operating Activities:
|
||||
|
Net income
|
$
|
|
||
|
Adjustments to reconcile net income to net cash used in operating activities:
|
||||
|
Formation, general and administrative expenses paid by Sponsor in exchange for issuance of Class B ordinary shares
|
|
|||
|
Income earned on cash and marketable securities held in Trust Account
|
( |
)
|
||
|
Changes in operating assets and liabilities:
|
||||
|
Prepaid expenses
|
( |
)
|
||
|
Due to related party
|
|
|||
|
Accrued expenses
|
|
|||
|
Accounts payable
|
|
|||
|
Net cash used in operating activities
|
( |
)
|
||
|
Cash Flows from Investing Activities:
|
||||
|
Purchase of treasury securities in Trust Account
|
( |
)
|
||
|
Net cash used in investing activities
|
( |
)
|
||
|
Cash Flows from Financing Activities:
|
||||
|
Proceeds from sale of Units
|
|
|||
|
Proceeds from sale of Private Placement Units
|
|
|||
|
Payment of underwriting fee
|
( |
)
|
||
|
Payment of Promissory Note – related party
|
( |
)
|
||
|
Proceeds from Promissory Note – related party
|
|
|||
|
Payment of offering costs
|
( |
)
|
||
|
Net cash provided by financing activities
|
|
|||
|
Net Change in Cash
|
|
|||
|
Cash – Beginning of period
|
|
|||
|
Cash – End of period
|
$
|
|
||
|
Supplemental Non-Cash Investing and Financing Activities:
|
||||
|
Deferred offering costs included in accrued offering costs
|
$
|
|
||
|
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares
|
$
|
|
||
|
Deferred underwriter fee payable
|
$
|
|
||
|
Remeasurement of Class A ordinary shares subject to possible redemption
|
$
|
|
||
|
●
|
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
|
|
|
●
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets
or quoted prices for identical or similar instruments in markets that are not active; and
|
|
|
●
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation
techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
For the Period from July 25, 2025
|
||||||||||||
|
(Inception) through
|
||||||||||||
|
December 31, 2025
|
||||||||||||
|
Class A
|
Class A
|
Class B
|
||||||||||
|
Redeemable
|
Non-redeemable
|
Non-redeemable
|
||||||||||
|
Basic net income per ordinary shares:
|
||||||||||||
|
Numerator:
|
||||||||||||
|
Allocation of net income, basic
|
$
|
|
$
|
|
$
|
|
||||||
|
Denominator:
|
||||||||||||
|
Basic weighted average ordinary shares outstanding
|
|
|
|
|||||||||
|
Basic net income per ordinary share
|
$
|
|
$
|
|
$
|
|
||||||
|
Diluted net income per ordinary shares:
|
||||||||||||
|
Numerator:
|
||||||||||||
|
Allocation of net income, diluted
|
$
|
|
$
|
|
$
|
|
||||||
|
Denominator:
|
||||||||||||
|
Diluted weighted average ordinary shares outstanding
|
|
|
|
|||||||||
|
Diluted net income per ordinary share
|
$
|
|
$
|
|
$
|
|
||||||
|
Gross proceeds from Initial Public Offering
|
$
|
|
||
|
Less:
|
||||
|
Proceeds allocated to Public Warrants
|
( |
)
|
||
|
Offering costs allocated to Class A ordinary shares subject to possible redemption
|
( |
)
|
||
|
Plus:
|
||||
|
Accretion of Class A ordinary shares subject to possible redemption
|
|
|||
|
Class A ordinary shares subject to possible redemption at December 31, 2025
|
$
|
|
|
|
December
31,
2025
|
|||
|
Cash
|
$
|
|
||
|
Cash and marketable securities held in Trust Account
|
$
|
|
||
|
For the
Period
from July
25, 2025
(Inception)
through
December
31,
2025
|
||||
|
Formation, general and administrative expenses
|
$
|
|
||
|
Income earned on cash and marketable securities held in Trust Account
|
$
|
|
||
| ● |
in whole and not in part;
|
| ● | at a price of $ |
| ● | upon a minimum of 30 days’ prior written notice of redemption (the “ |
| ● | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $ |
|
Level
|
December 31,
2025
|
|||||||
|
US$
|
||||||||
|
Assets:
|
||||||||
|
Cash and marketable securities held in Trust Account
|
1
|
$
|
|
|||||
|
December 4,
2025
|
||||
|
Implied ordinary share price
|
$
|
|
||
|
Exercise price
|
$
|
|
||
|
Simulation term (years)
|
|
|||
|
Risk-free rate
|
|
%
|
||
|
Estimated implied volatility
|
|
%
|
||
|
Market adjustment
|
|
%
|
||
|
Calculated value per warrant
|
$
|
|
||